zuma-1 trial observations
Published 5 years ago • 99 plays • Length 3:31Download video MP4
Download video MP3
Similar videos
-
3:32
zuma-1: updated data and future prospects
-
4:19
the pivotal zuma-1 trial for nhl
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
2:00
zuma-1 trial: fda approval and follow-up of car t-cell product axicabtagene ciloleucel
-
1:44
comparison of zuma-1 and scholar-1 outcomes
-
2:09
zuma series update: zuma-1 and zuma-2
-
0:54
insights into the zuma-23 trial: axi-cel in frontline high-risk lbcl
-
2:00
long-term follow-up results of the zuma-1 trial of anti-cd19 car t-cells for non-hodgkin lymphoma
-
26:31
survival analysis overview
-
43:53
chapter 1 basic hematology ( introduction )
-
8:11
what is hematology oncology?
-
2:24
zuma-1: a pivotal trial of axicabtagene ciloleucel (axi-cel; kte-c19) in patients with nhl
-
2:48
zuma-1: safety and efficacy of axicabtagene in refractory non-hodgkin lymphoma patients
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
3:05
zuma-1, juliet and transcend trials: changing the treatment landscape for r/r nhl
-
2:17
zuma-12: axicabtagene ciloleucel as a first-line therapy in patients with high-risk lbcl
-
1:15
primary overall survival analysis of the zuma-7 trial
-
2:19
zuma-3: identifying the optimal dose of axi-cel in r/r all
-
2:06
zuma-12: axi-cel as first-line therapy in high-risk large b-cell lymphoma
-
3:10
zuma-9: expanded access protocol and oos axicabtagene ciloleucel in r/r dlbcl
-
3:49
zuma-3: impact of prior blinatumomab and allosct